Analytical Data
-
Gene name
PNLIPRP1
- Application
-
Alternative Names
Short name:PL-RP1
-
Species
Dog
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P06857
-
Expression Region
18-467aa
-
Molecular Weight
65.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PNLIPRP1, or Pancreatic Lipase-Related Protein 1, is a member of the lipase family, which plays a crucial role in lipid metabolism. This protein is predominantly expressed in the pancreas and is involved in the hydrolysis of dietary fats. Recent studies have highlighted its potential functions beyond lipid digestion, including implications in metabolic disorders, obesity, and diabetes. Given the increasing prevalence of these conditions, understanding the structure and function of PNLIPRP1 has gained significant interest. Research indicates that changes in PNLIPRP1 expression may correlate with altered lipid profiles and contribute to the development of metabolic diseases. Furthermore, recombinant PNLIPRP1 is of interest for functional studies and potential therapeutic applications. The production and characterization of recombinant PNLIPRP1 can facilitate the exploration of its enzymatic activity, substrate specificity, and regulatory mechanisms. Investigating the interactions of PNLIPRP1 with other proteins and pathways involved in lipid metabolism will provide deeper insights into its physiological roles. Overall, the study of PNLIPRP1 represents a promising avenue for understanding and addressing metabolic disorders related to lipid metabolism.
